Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus
Patients with type 2 diabetes mellitus have an increased risk of cardiovascular (CV) complications. Although hyperglycaemia contributes to the pathogenesis of atherosclerosis and heart failure in these patients, glucose-lowering strategies did not have a significant effect on reducing CV risk, parti...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/df96db84249147979cbed089b1755da3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!